-
effectivehealthcare.ahrq.gov/sites/default/files/ch_2-user-guide-to-ocer_130129.pdf
January 01, 2011 - Background
and rationale for the sequenced treatment
alternatives to relieve depression (STAR*D) study
-
www.ahrq.gov/workingforquality/events/webinar-using-measurement-for-quality-improvement.html
November 01, 2016 - patient-reported outcome measures in our clinician reporting programs such as improvement in or change in depression
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs023844-federman-final-report-2017.pdf
January 01, 2017 - Privacy concerns
Concern about exposure of personal information, e.g., history or diagnosis of depression
-
digital.ahrq.gov/sites/default/files/docs/citation/pghd-practical-guide.pdf
December 01, 2021 - This goes for treatment
of everything from depression to hypertension. … (e.g.,
hypertension, depression, diabetes)
Does PGHD integration fill a patient care gap or unmet patient … (e.g., improve BP control, monitor
symptoms of depression or anxiety, IVF/fertility medicine, lose weight
-
effectivehealthcare.ahrq.gov/health-topics/elder-abuse
-
psnet.ahrq.gov/node/73899/psn-pdf
September 29, 2021 - Lost in Transitions of Care: Managing an Opioid-
Dependent Patient with Frequent Hospitalizations
September 29, 2021
Tan F, Johl K, Kotova M. Lost in Transitions of Care: Managing an Opioid-Dependent Patient with Frequent
Hospitalizations. PSNet [internet]. 2021.
https://psnet.ahrq.gov/web-mm/lost-transitions-care…
-
www.ahrq.gov/sites/default/files/2024-02/handler-report.pdf
January 01, 2024 - Final Progress Report: Enhancing the Detection and Management of Adverse Drug Events in the Nursing Home
TITLE PAGE
AHRQ Final Progress Report
Title: Enhancing the Detection and Management of Adverse Drug Events in the Nursing Home
Principle Investigator: Steven M. Handler, MD, PhD
Team Members: Joseph T. Hanlon…
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/cahps-database/2016_cg_cahps_chartbook.pdf
January 01, 2016 - 2016 CAHPS Clinician & Group Survey Database Chartbook
THE CAHPS DATABASE
2016 CAHPS Clinician & Group Survey Database
2016 Chartbook: What Patients Say About Their
Health Care Providers and Medical Practices
The content of this document may be used and reprinted without permi…
-
hcup-us.ahrq.gov/db/tools/Dx_Pr_Grps_Formats.TXT
December 28, 2023 - /* =============================================================================
Program : Dx_Pr_Grps_Formats.txt …
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol3/Phillips.pdf
January 01, 2004 - The AAFP Patient Safety Reporting System: Development and Legal Issues Pertinent to Medical Error Tracking and Analysis
121
The AAFP Patient Safety Reporting System:
Development and Legal Issues Pertinent to
Medical Error Tracking and Analysis
Robert L. Phillips, Susan M. Dovey, John S. Hickner,
Deborah Graha…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research.pdf
July 01, 2012 - Depression YES NO
k. Memory problems YES NO
l. Chronic pain YES NO
m. … Heart Failure □ Osteoarthritis
□ Coronary Artery Disease □ Hepatitis □ Osteoporosis
□ Depression
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_executive.pdf
December 01, 2012 - Organization for Research and Treatment of Cancer Quality of Life
Questionnaire and Hamilton Rating Scale for Depression … No significant difference was observed in depression
scores pre- and post-treatment.64
Length of
Stay
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ongoing-studies-evidence_research.pdf
December 01, 2010 - Studies:
Clinicaltrials.gov
Number of
Ongoing
Studies:
Other
Sources
Post-Myocardial Infarction Depression … Yes Narrative
with 12
“Considera-
tions”
highlighted
Year:
December
2004
1 0
Perinatal Depression
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
October 29, 2012 - Duloxetine was no better
than placebo in women with depression,
diabetes, and chronic lung diseases … Duloxetine was
no better than placebo in women with depression, diabetes,
and chronic lung diseases
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/We5A-uCMvX5qYeFukGgqks
March 01, 2004 - vs. 47
Fever (%):
56 vs. 38 vs. 43
Myalgia (%):
50 vs. 42 vs. 42
Nausea (%):
33 vs. 26 vs. 29
Depression … =0.01) Myalgia (%):
50 vs. 48 vs. 56
Fever (%):
33 vs. 44 vs. 46
Diarrhea (%):
17 vs. 16 vs. 22
Depression
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-screening-2002
September 03, 2002 - distinguishes cancer screening from other screening services considered by the USPSTF, such as chlamydia, depression … Short- and long-term anxiety and depression in women recalled after breast cancer screening.
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/edenvironmentalscan/edenvironmentalscan.pdf
December 01, 2014 - These included
asthma, heart disease, depression, hypertension, and other comorbidities. … hour return (8.4% vs. 4.4%).31 Among those age 65 years and older,
having heart disease (OR 1.45) or depression
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary25/screening-for-abnormal-blood-glucose-and-type-2-diabetes-october-2015
April 13, 2015 - Predictors of anxiety and depression among people attending diabetes screening: a prospective cohort … invited to screening increased anxiety vs. not being invited; in longer-term follow-up (>1 y), anxiety or depression
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/hepatitis-c-virus-infection-screening-2004
March 08, 2004 - . 47
Fever (%): 56 vs. 38 vs. 43
Myalgia (%): 50 vs. 42 vs. 42
Nausea (%): 33 vs. 26 vs. 29
Depression … 62
Myalgia (%): 50 vs. 48 vs. 56
Fever (%): 33 vs. 44 vs. 46
Diarrhea (%): 17 vs. 16 vs. 22
Depression
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/R3y9LSud52CGL8mG4wvxoT
June 09, 2020 - medications for opi-
oid use disorder on health outcomes (eg, such as global function,
quality of life, depression … Anhedonia, depression, anxiety, and craving in
opiate dependent patients stabilized on oral
naltrexone